Accent Capital Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Accent Capital Management's IDXX Position: Q2 2026 in Review
Accent Capital Management increased its Idexx Laboratories (IDXX) stake by 29% in Q2 2026, buying an estimated $1.12K and bringing the position to 9 shares worth $4.74K. The position accounts for ﹤0.01% of the portfolio, ranked #287.
Accent Capital Management first reported a position in IDXX in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.36K in Q2 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Accent Capital Management held 9 shares of Idexx Laboratories worth $4.74K as of Q2 2026.
- Accent Capital Management bought 2 Idexx Laboratories shares in Q2 2026, an estimated $1.12K.
- Idexx Laboratories made up ﹤0.01% of Accent Capital Management's portfolio in Q2 2026, its #287 holding.
- Accent Capital Management first reported a position in Idexx Laboratories in Q2 2025 and has held it in 5 quarters since.
- Accent Capital Management's Idexx Laboratories position peaked at $5.36K in Q2 2025.
- 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Accent Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.